Problematic nail conditions range from nail psoriasis (NP) to paronychia, which are commonly seen in clinical practice and result from infectious, inflammatory, neoplastic and traumatic etiologies. A ...

We all have those moments where we find ourselves self-consciously hiding our nails. Maybe it’s because they’re nibbled or nicked, or in desperate need of a good cuticle taming. Luckily, in most cases ...

HealthDay News — Treatment recommendations have been developed for patients with nail psoriasis. The recommendations were published in JAMA Dermatology. “There is an unmet need for treatment ...

(HealthDay News) — Treatment recommendations have been developed for patients with nail psoriasis. The recommendations were published online December 3 in JAMA Dermatology. Jeffrey J. Crowley, MD, ...

Psoriasis can affect your nails, too. When it does it's called nail psoriasis. Most people develop nail psoriasis years after psoriasis begins. It's also possible to have nail psoriasis without signs ...

Psoriasis can affect the fingers, knuckles, nails, palms, and soles. Here’s what this psoriasis looks like and how to relieve symptoms like itch.

(HealthDay News) — Tofacitinib is associated with improvements in nail psoriasis, according to a study published in the the Journal of the American Academy of Dermatology. Joseph F. Merola, MD, from ...

Nail problems affect nearly 10% of adults, with fungal infections outnumbering psoriasis cases by almost three to one. This prevalence disparity leads many people to automatically assume any nail ...

Intralesional injections of triamcinolone acetonide are widely used to treat nail psoriasis and other inflammatory nail conditions. But information on optimal dosing has been largely elusive -- until ...

Most patients with psoriasis have variable nail involvement with clinical manifestations, including irregular pitting, "oil spot" discoloration of the nail bed, and onycholysis. Additional secondary, ...

Nail involvement was shown to reduce the effectiveness of ustekinumab in the treatment of moderate to severe psoriasis, whereas secukinumab exhibited overall higher efficacy than ustekinumab and ...

C. Blome, A. Costanzo, E. Dauden, C. Ferrandiz, G. Girolomoni, R. Gniadecki, L. Iversen, A. Menter, K. Michaelis-Wittern, A. Morita, H. Nakagawa, K. Reich and M ...